← Insider buys

IRTC

iRhythm Holdings, Inc. · Healthcare

Insiders bought $57K of iRhythm Holdings, Inc. in the last 12 months

1 insider bought on 1 day.

$57KBought, 12 mo
$23.9MSold, 12 mo
$3.5BMarket cap

IRTC over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

IRTC after insider buys

3 months after each buy, from the first price a copier could get.

+19.4%Average
+12.0 ptsVs S&P 500
3 of 3Higher

3 buys since 2023 with 3 months of prices.

Congress

Members reported 1 trade in IRTC since 2025.

Every filing

189 insider filings since 2017, newest first

IRTCSell

Daniel G. Wilson · Chief Financial Officer

$94K−2.2%Sep 3
IRTCSell

Quentin S. Blackford · President and CEO

$3.3M−10.6%Aug 11
IRTCSell

Patrick Michael Murphy · CBO and CLO

$884K−9.2%Aug 11
IRTCSell

Chad Patterson · Chief COMM & Product Officer

$884K−10.2%Aug 11
IRTCSell

Sumi Shrishrimal · EVP and Chief Risk Officer

$670K−10.7%Aug 11
IRTCSell

Minang Turakhia · Chief Med/sci OFCR EVP Advtech

$884K−10.6%Aug 11
IRTCSell

Mervin Smith · EVP Strategic Business Ops

$75K−2.7%Aug 4
IRTCSell

Julianne Rodda · EVP and Chief People Officer

$258K−10.4%Aug 4
IRTCSell

Chad Patterson · Chief COMM & Product Officer

$331K−4.6%Aug 4
IRTCSell

Minang Turakhia · Chief Med/sci OFCR EVP Advtech

$177K−2.6%Jul 6
IRTCSell

Sean Clinton Freeman · EVP, Strategy & Corp Devt

$114K−6.3%Jul 6
IRTCSell

Sumi Shrishrimal · EVP and Chief Risk Officer

$186K−4.1%Jun 3
IRTCSell

Marc Wade Rosenbaum · Chief Accounting Officer

$79K−4.3%Jun 3
IRTCBuy

Abhijit Y Talwalkar · Director

$57K+35.0%May 12
IRTCSell

Brian Lee Lawrence · CTO

$122K−5.0%May 5
IRTCSell

Mervin Smith · EVP Strategic Business Ops

$295K−10.0%Mar 17
IRTCSell

Minang Turakhia · Chief MED, SCI OFCR EVP Advtec

$517K−7.0%Mar 3
IRTCSell

Sumi Shrishrimal · EVP and Chief Risk Officer

$363K−6.0%Mar 3
IRTCSell

Mervin Smith · EVP Strategic Business Ops

$174K−5.0%Mar 3
IRTCSell

Chad Patterson · Chief Comm, Product Officer

$571K−7.0%Mar 3
IRTCSell

Patrick Michael Murphy · CBO, CLO

$560K−6.0%Mar 3
IRTCSell

Marc Wade Rosenbaum · Chief Accounting Officer

$105K−5.0%Mar 3
IRTCSell

Daniel G. Wilson · CFO

$436K−9.0%Mar 3
IRTCSell

Quentin S. Blackford · President and CEO

$1.8M−6.0%Mar 3
IRTCSell

Daniel G. Wilson · CFO

$703K−14.0%Feb 26
IRTCSell

Minang Turakhia · Chief MED, SCI OFCR EVP Advtec

$1.1M−14.0%Feb 26
IRTCSell

Mervin Smith · EVP Strategic Business Ops

$547K−17.0%Feb 26
IRTCSell

Sumi Shrishrimal · EVP and Chief Risk Officer

$842K−14.0%Feb 26
IRTCSell

Marc Wade Rosenbaum · Chief Accounting Officer

$650K−24.0%Feb 26
IRTCSell

Chad Patterson · Chief Comm, Product Officer

$1.2M−15.0%Feb 26
IRTCSell

Patrick Michael Murphy · CBO, CLO

$1.1M−11.0%Feb 26
IRTCSell

Quentin S. Blackford · President and CEO

$3.5M−12.0%Feb 26
IRTCSell

Marc Wade Rosenbaum · Chief Accounting Officer

$39K−3.0%Feb 25
IRTCSell

Mervin Smith · EVP Strategic Business Ops

$103K−5.0%Feb 25
IRTCSell

Abhijit Y Talwalkar · Director

$774K−21.0%Feb 24
IRTCSell

Chad Patterson · Chief Comm, Product Officer

$52K−1.0%Dec 3
IRTCSell

Patrick Michael Murphy · CBO, CLO

$458K−4.0%Dec 3
IRTCBuy

Abhijit Y Talwalkar · Director

$501K+54.0%Nov 5
IRTCSell

Quentin S. Blackford · President and CEO

$1.2M−9.0%Nov 5
IRTCSell

Brice Bobzien · CFO

$97K−5.0%Aug 12
IRTCSell

Chad Patterson · Chief Commercial Officer

$225K−8.0%Aug 5
IRTCSell

Mervin Smith · EVP Strategic Business Ops

$51K−6.0%Aug 5
IRTCSell

Minang Turakhia · EVP, CMO and CSO

$148K−5.0%Jul 3
IRTCSell

Sumi Shrishrimal · EVP and Chief Risk Officer

$101K−5.0%Jun 5
IRTCSell

Marc W. Rosenbaum · Chief Accounting Officer

$45K−6.0%Jun 5
IRTCSell

Mark J. Day · CTO

$361K−5.0%Mar 5
IRTCSell

Chad Patterson · Chief Commercial Officer

$120K−3.0%Mar 5
IRTCSell

Quentin S. Blackford · President and CEO

$469K−2.0%Mar 5
IRTCSell

Patrick Michael Murphy · CBO, CLO

$169K−3.0%Mar 5
IRTCSell

Minang Turakhia · EVP, CMO and CSO

$105K−3.0%Mar 5
About iRhythm Holdings, Inc.

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.